• Widely-used pesticide may double Parkinson’s risk, study suggests
    Parkinson's8 Jan

    Long-term residential exposure to chlorpyrifos is linked to more than a 2.5-fold higher risk of Parkinson's, a study suggests. The research combines human population data with lab experiments showing how the pesticide damages dopamine-producing brain cells (neurons that make the signalling chemical dopamine), providing biological evidence for the link. Around 166,000 people in the UK [...]

  • NICE recommends drug for hard-to-control MS
    Multiple sclerosis7 Jan

    NICE has recommended natalizumab, sold as Tysabri and Tyruko, as an option for certain people with hard-to-control multiple sclerosis. The decision by the National Institute for Health and Care Excellence will allow NHS coverage of the drug in England, with decisions also influencing NHS coverage in other parts of the UK. The guidance specifically recommends [...]

  • Wireless EEG tracks neuroplasticity in trials
    Tech & industry6 Jan

    Researchers validated a wireless EEG method to measure neuroplasticity, offering a non-invasive way to track how the brain responds to new treatments. The approach could provide an objective readout of brain response to therapies for psychiatric and neurodegenerative conditions. Neuroplasticity is the brain’s ability to reorganise its connections after experience, injury or disease, for example [...]

  • Psychopathic traits linked to much higher risk of schizophrenia, study finds
    Neuropsychology5 Jan

    People with high psychopathic traits face a 9.3 times higher schizophrenia risk than those with low traits, research suggests. The study also found that individuals classified as psychopathic were 2.37 times more likely to develop the condition than their non-psychopathic peers. Psychopathic traits are personality features involving shallow emotion, reduced empathy and limited remorse for [...]

  • Biomarker could identify patients most likely to benefit from new MS drugs
    Multiple sclerosis5 Jan

    An MS biomarker linked to disease progression could flag patients most likely to benefit from new drugs, researchers say. The findings were validated in mice and humans and could shape how clinical trials are run for progressive forms of the disease. The study examined “compartmentalised inflammation” (immune activity contained within the brain and spinal cord [...]

  • Oily fish and wholegrain bread may lower MS risk
    Multiple sclerosis18 Dec

    Eating more oily fish and wholegrain bread may cut the risk of multiple sclerosis, a study using UK Biobank data suggests. The findings add to evidence that diet is a modifiable factor in preventing the disease. Multiple sclerosis (MS) occurs when the immune system attacks myelin, the protective coating on nerve fibres in the brain [...]

  • Researchers develop rapid ALS blood test
    MND / ALS17 Dec

    A new ALS blood test can identify the disease from a single blood draw with 97 per cent accuracy, researchers say. The test can also rule out people who do not have ALS, potentially ending long diagnostic delays. ALS, or amyotrophic lateral sclerosis, is a paralysing disease caused by the death of motor neurones. [...]

  • Study reveals how visual system recovers after brain injury
    Brain injury16 Dec

    In a recent study, Johns Hopkins University researchers used mice to explore how the visual brain system recovers following traumatic injury.  The researchers monitored connections from cells in the eye to the brain after injury. They discovered that surviving cells compensated for cell death by sprouting extra branches to make connections with more neurons in the brain.   This sprouting occurred to such an extent that connections [...]

  • Research reveals why mild brain injury can trigger Alzheimer’s
    Brain injury16 Dec

    New research explains how a single mild brain injury can set off changes that increase the risk of Alzheimer’s disease. The discovery points to a possible way to prevent the disorder by repairing the brain’s drainage system after head trauma. Scientists found that traumatic brain injuries impair lymphatic vessels that connect the brain and the [...]

  • Research links enzyme to stroke and MS
    Stroke12 Dec

    The enzyme CEMIP is tied to myelin damage seen in multiple sclerosis, stroke and Alzheimer's, new research has revealed, pointing to a new target for brain repair. Researchers aim to develop ways to target the enzyme to heal or slow disease. The study, from Oregon Health & Science University, found that cell migration inducing and [...]